IP Verse

Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations

EP3345604

H. LUNDBECK A/S
Application Number
EP17206034A
Filing Date
Jun 27, 2013
Status
Granted And Under Opposition
May 5, 2023
Grant Date
Jun 7, 2023
External Links
Slate, Register

Biblio Summary

The patent EP3345604B1 was granted on Jun 7, 2023 by H. Lundbeck A/S The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOGARANMar 6, 2024ADMISSIBLE
ALFRED E. TIEFENBACHER (GMBH & CO. KG)Mar 1, 2024ADMISSIBLE

More Opposed Patents of H. Lundbeck A/S

The table below shows the patents of H. Lundbeck A/S that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2608789Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]PiperazineAug 21, 20241
EP3615518Process For The Manufacture Of Vortioxetine Hbr Alpha-FormDec 15, 20211
EP3138564Nalmefene For Reduction Of Alcohol Consumption In Specific Target PopulationsJan 31, 20181

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents